Science Daily - Heart Disease
MAY 1, 2024
A simple blood test could allow doctors to determine whether a person may be at higher risk for stroke or cognitive decline during their lifetime, according to a new study.
Medical Xpress - Cardiology
MAY 1, 2024
A simple blood test could allow doctors to determine whether a person may be at higher risk for stroke or cognitive decline during their lifetime, according to a new UCLA Health study.
Journal of Cardiovascular Pharmacology
APRIL 8, 2024
Multiple studies have shown that long non-coding RNAs (lncRNAs) play a significant role in the progression of cardiovascular and cerebrovascular diseases. Multiple studies have shown that long non-coding RNAs (lncRNAs) play a significant role in the progression of cardiovascular and cerebrovascular diseases.
Open Heart
NOVEMBER 9, 2024
Patients with IONM were more likely to have had baseline cerebrovascular disease (60% vs 22%). IONM may serve as a biomarker of cerebral ischaemia, and empirical adjustments based on changes may provide benefits for neurologic outcomes in high-risk patients. Patients with IONM had increased operative mortality (5.3%
Stroke Journal
JANUARY 18, 2024
Accumulating evidence supports a link between sleep disorders, disturbed sleep, and adverse brain health, ranging from stroke to subclinical cerebrovascular disease to cognitive outcomes, including the development of Alzheimer disease and Alzheimer disease–related dementias. Stroke, Ahead of Print.
Hypertension Journal
JANUARY 2, 2024
Hypertension is the primary modifiable risk factor for cardiovascular, renal, and cerebrovascular diseases and is considered the main contributing factor to morbidity and mortality worldwide. Hypertension, Ahead of Print.
Frontiers in Cardiovascular Medicine
FEBRUARY 13, 2024
By comparing myocardial injury patients with non-myocardial injury patients, notable differences were observed in age, pre-existing medical conditions (e.g.,
Expert insights. Personalized for you.
105 
Let's personalize your content